Morphology tunable and acid-sensitive dextran–doxorubicin conjugate assemblies for targeted cancer therapy

• DOI: 10.1039/d0tb00746c
• Publication Date: 2020-04-24T12:03:55Z
• Authors: Qingfei Zhang; Shasha He; Gaizhen Kuang; Sha Liu; Hongtong Lu; Xiaoyuan Li; Dongfang Zhou; Yubin Huang
• Keywords: Drug Carriers; Antineoplastic Agents; Dextrans; Hydrogen-Ion Concentration; 01 natural sciences; 0104 chemical sciences; 3. Good health; Folic Acid; Doxorubicin; Cell Line, Tumor; Humans; Molecular Targeted Therapy

Morphology tunable and acid-sensitive dextran–doxorubicin conjugate assemblies (DD-M and DDF-V) were developed for targeted cancer therapy.